points by timr 2 days ago | 0 comments
It doesn’t. That’s what I mean when I tell you the bottleneck is somewhere else. Obviously everyone claims that they do this with new technology X, but empirically, it isn’t helpful.
Re-ranking pre-clinical leads is the scientific equivalent of that old saying about opinions.
[–] menaerus 2 days ago
[–] timr 1 day ago
There is no objective function you can optimize your way to a drug discovery machine, let alone a fundamental understanding of how the underlying system works.
[–] menaerus 1 day ago